Post-earnings recap
Reported
Wed, Apr 28, 2021
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report indicates that Teladoc Health is facing significant challenges, particularly with its EPS falling short of expectations. The stock reacted negatively, declining by 1.92%, reflecting investor concerns about the company's profitability and future growth prospects. Without guidance, investors may remain cautious about the company's direction in the coming quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.31 | N/A | -122.41% |
| Revenue | N/A | N/A | N/A |
Management expressed concern over current market conditions impacting growth. They emphasized a focus on long-term strategies despite short-term setbacks.
Management did not provide specific revenue guidance for the upcoming quarters.
The company acknowledged challenges in achieving profitability in the near term.